Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Workman

Showing results (101-110 of 268) with videos related to

Pageof 27
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1989
Inhibition of cellular esterases by the antitumour imidazotetrazines mitozolomide and temozolomide: demonstration by flow cytometry and conventional spectrofluorimetryC Dive, P Workman, J V Watson
Cancer Research|February 1, 1991
Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cellsC Dive, J V Watson, P Workman
Biochemical Pharmacology|November 1, 1987
Novel dynamic flow cytoenzymological determination of intracellular esterase inhibition by BCNU and related isocyanatesC Dive, P Workman, J V Watson
Anti-Cancer Drug Design|August 1, 1994
Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitorV G Brunton, S Carlin, P Workman
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Pharmacokinetics, distribution, and metabolism of the novel bioreductive alkylating indoloquinone EO9 in rodentsP Workman, M Binger, K L Kooistra
Cancer Treatment Reports|July 1, 1983
Effects of cimetidine, antipyrine, and pregnenolone carbonitrile on misonidazole pharmacokineticsP Workman, J Donaldson, N C Smith
Biochemical Pharmacology|January 1, 1986
Benznidazole: nitroreduction and inhibition of cytochrome P-450 in chemosensitization of tumour response to cytotoxic drugsP Workman, M I Walton, F Y Lee
Biochemical Pharmacology|July 22, 1992
The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liverM I Walton, C R Wolf, P Workman
British Journal of Cancer|March 1, 1991
Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpressionH M Coley, P Workman, P R Twentyman
British Journal of Cancer|March 1, 1978
Different esterase activities of exponential and plateau phases of EMT6 cells monitored by flow cytofluorimetryJ V Watson, P Workman, S H Chambers
Pageof 27

Showing results (101-110 of 268) with videos related to

Sort By:
Pageof 27
Cancer Chemotherapy and Pharmacology|January 1, 1989
Inhibition of cellular esterases by the antitumour imidazotetrazines mitozolomide and temozolomide: demonstration by flow cytometry and conventional spectrofluorimetryC Dive, P Workman, J V Watson
Cancer Research|February 1, 1991
Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cellsC Dive, J V Watson, P Workman
Biochemical Pharmacology|November 1, 1987
Novel dynamic flow cytoenzymological determination of intracellular esterase inhibition by BCNU and related isocyanatesC Dive, P Workman, J V Watson
Anti-Cancer Drug Design|August 1, 1994
Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitorV G Brunton, S Carlin, P Workman
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Pharmacokinetics, distribution, and metabolism of the novel bioreductive alkylating indoloquinone EO9 in rodentsP Workman, M Binger, K L Kooistra
Cancer Treatment Reports|July 1, 1983
Effects of cimetidine, antipyrine, and pregnenolone carbonitrile on misonidazole pharmacokineticsP Workman, J Donaldson, N C Smith
Biochemical Pharmacology|January 1, 1986
Benznidazole: nitroreduction and inhibition of cytochrome P-450 in chemosensitization of tumour response to cytotoxic drugsP Workman, M I Walton, F Y Lee
Biochemical Pharmacology|July 22, 1992
The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liverM I Walton, C R Wolf, P Workman
British Journal of Cancer|March 1, 1991
Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpressionH M Coley, P Workman, P R Twentyman
British Journal of Cancer|March 1, 1978
Different esterase activities of exponential and plateau phases of EMT6 cells monitored by flow cytofluorimetryJ V Watson, P Workman, S H Chambers
Pageof 27